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The glow gives it away. A new assay uses the firefly luciferase reporter gene, which luminesces in the
presence of the Ah receptor, to testforthe presence of dioxins in environmental samples.
compounds in the environment, there is a
need for a rapid, inexpensive screening assay
to monitor toxic output at a given site, to
detect the presence of these chemicals in
individuals who work in such environments,
and to test sites in which these chemicals are
believed to be deposited," says Michael
Denison, professor ofenvironmental toxicol-
ogy at the University of California at Davis
and one ofthe assay's inventors.
Denison and his colleagues have studied
human, rat, guinea pig, hamster, and mouse
cells, and are currently experimenting with a
fish cell line. Testing is carried out by placing
the environmental specimen in a test plate
with the recombinant cells. The cells contain
the luciferase reporter gene, which is linked
to a DNA sequence called a dioxin-respon-
sive element (DRE). The DRE is the bind-
ing site for the dioxin-activated aryl hydro-
carbon receptor (AhR), a cell protein that
mediates the toxic effects of dioxins. When
the cells are exposed to dioxin-like com-
pounds present in environmental samples,
the AhR is activated and stimulates expres-
sion of the luciferase gene via the DRE.
Luciferase can be easily measured because it
emits light.
EPA regulations require an assay of the
concentration of individual dioxin-like com-
pounds in an environmental sample using
high-resolution gas chromatography coupled
with high-resolution mass spectrometry.
Results for the individual compounds are
then multiplied by a toxic equivalency factor
to arrive at the total toxic equivalency for the
mixture of toxinis. This is a slow, cumber-
some, and expensive process. The CALUX
system detects the presence of such chemi-
cals, but does not indicate which individual
chemical or combination is present. Still, it is
a rapid and inexpensive screening method,
Denison explains.
"This [system] is a natural progression
from the current bioassay," says Denison.
"The previous bioassay, [using] the H4IIE
wild-type cells, lacks much of the selectivity
and sensitivity that the CALUX system has.
An advantage or our system is that luciferase
reporter activity is unaffected by chemicals
that are known to inhibit activity in the
H4IIE assay."
The bioassay is so promising that it is
now the object of a commercial enterprise.
George Clark, president of Xenobiotic
Detection Systems, Inc. in Durham, North
Carolina, is marketing the assay to environ-
mental researchers. "Currently we're offer-
ing analyses ofblood, serum, milk, water, or
sediment in parts per trillion of 2,3,7,8-
tetrachlorodibenzo-p-dioxin equivalents.
We're seeking regulatory approval for our
assay as a screening method that can be con-
firmed by gas chromatography-mass spec-
trometry, which should provide significant
savings in the analysis of the toxicity of this
class ofcompounds," Clark says.
The bioassay is not a test that can cur-
rently be run in the field, but specimens can
be collected, frozen, and forwarded to the
laboratory for assay. "However," says Clark,
"we're developing a mobile laboratory that
can be parked at the site of investigation in
areas that require a large number oftests."
"The strong point ofthis assay is its speed
and potential as a screening method," accord-
ing to Scott Masten, a fellow in the
Environmental Toxicology Program at the
NIEHS who is familiar with the assay. "Using
the chromatograph-spectrometer method you
could assay perhaps two dozen specimens in a
week. This bioassay can screen a hundred
specimens in a week and only those that show
activity, that luminesce, need to be run
through the chromatograph and spectrome-
ter. The bioassay will be even faster if it is
automated, which can be done. Ihe major
disadvantage of the CALUX method is the
problem with specificity. It measures total
dioxin-like activity in the specimen without
indicating which chemicaals are present. The
active sample still must be analyzed by chro-
matograph and spectrometer, but even so, the
bioassay is around 20% the cost of the chro-
matograph-spectrometer."
A New Way to Control
Experiments
In case-control studies in which a
researcher is trying to determine how genet-
ics and environmental exposure interact to
cause illness, the job of being a control is
not very appealing. Controls must fill out
questionnaires that will determine if they
have been exposed to the environmental
agent, supply tissue samples for the genetic
analysis (which normally involves a needle
prick), and perhaps suffer the anxiety of
questions raised by the genetic analysis
itself, including how they will be affected if
the analysis shows a genetic susceptibility to
illness. For study subjects that have a dis-
ease, there is at least the hope that the
research will lead to a new treatment for
their ailment, but for the healthy control
even this comfort is missing. It is not
unusual for many controls to quit in the
middle of a study on genetic susceptibility
to environmental exposures. Sometimes so
many quit that the study loses its validity.
However, according to two NIEHS
research statisticians, in most studies of this
type, the effect ofthe gene-exposure interac-
tion can be found without using a control
group. David Umbach and Clarice
Weinberg report in the 15 August 1997 issue
of Statistics in Medicine that if two assump-
tions can be made-that the disease or con-
dition under investigation is rare in the gen-
eral population and that the exposure of
interest and the genetic condition are not
statistically related-mathematical analysis of
the gene-exposure interaction can progress
with no data from controls at all.
The drawback to this method is that
without data on the exposure history or on
the genetic makeup of a control group, only
the combined effect of the susceptible geno-
type and the exposure can be found. Neither
the effect of the exposure alone nor of the
genotype alone can be assessed.
Since it is less difficult (and less expen-
sive) to convince a group of controls to fill
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out a questionnaire on exposure than it is to
collect blood samples and perform genetic
analysis, Umbach and Weinberg propose a
research method in which a control group is
used but not asked to supply tissue samples.
This method should erase most ofthe anxi-
ety for controls, while allowing the effect of
the gene-exposure interaction, as well as the
effect ofthe exposure alone, to be evaluated.
For example, in a study ofhow smoking
and a particular gene interact to cause lung
cancer, if the assumption of random occur-
rence of the gene among smokers and non-
smokers can be made, the combined effect of
the gene and smoking could be found with-
out using a control group. However, what
Weinberg and Umbach propose is that a
control group be used, but only to fill out
questionnaires about their smoking histories.
This would allow the researchers to also ana-
lyze what effect smoking alone has on the
incidence of lung cancer. The major draw-
back of this method is that it could not be
used to determine the effect ofthe genotype
alone, independent of smoking, as this
would require collecting genetic information
from the control group.
However, even in studies in which
uncovering the lone genotype effect is
important, Umbach and Weinberg report
that researchers can still save controls some
anxiety. This is because, even though the
genotype of controls is necessary to find the
genotype effect, it is not necessary to link
those genotypes to specific exposures or,
hence, to the individuals that supplied them.
Genetic information can be collected from a
control anonymously, without so much as a
number to link the data to a specific individ-
ual or exposure history. The important infor-
mation for determining the genotype effect,
according to Umbach and Weinberg, is the
total number of genetically susceptible con-
trols. Umbach and Weinberg suggest that
when statistical software is being employed
that requires the exposure and genotype of
each individual to be entered separately,
researchers can simply pair genotypes and
exposures randomly without harming the
validity ofthe study.
However, both methods of analysis'
described by the NIEHS researchers-using
no genetic data from controls and using only
anonymous data-rely on the crucial
assumption that the susceptible genotype
and the exposure vary independently in the
population. Neither analysis allows the valid-
ity of this assumption to be checked. The
researchers say that in most cases, though,
such a genotype-exposure relationship
would not be expected, and, indeed, the
independence of exposure and genetics is
often assumed in studies ofthis type.
Still, there are cases where Umbach and
Weinberg's method would not work. For
example, this method could not be used to
study how a gene that gives rise to skin color
interacts with lifetime exposure to sunlight to
cause skin cancer because it is probable that
people with the variant ofthe gene that leads
to very fair skin would avoid exposure to
sunlight more than other people would.
Thus, the exposure of interest would be
linked to the genetic condition, and a central
assumption of Umbach and Weinberg's
methodwould beviolated.
To show that there are many practical
applications for their method of analysis,
however, the authors present a reanalysis ofa
study ofhow maternal smoking and genetic
predisposition of infants interact to cause
cleft palates in newborns. In the original
study, blood samples from all the control
infants were available, but Umbach and
Weinberg show that similar results could
have been obtainedwithout these samples.
In cases like these, the ability to take
fewer blood samples could lower the cost
and time involved in the research project
while easing the anxieties of the control
subjects, ensuring their continued coopera-
tion and the ability of researchers to get at
the important questions on gene-environ-
ment interactions.
Battling over Asbestos in the
Third World
Health concerns have led many developed
countries in recent years to phase out the use
of asbestos. But demand for these fibrous
minerals has surged in the developing
world, and the asbestos industry continues
to flourish in nations such as China, Brazil,
and Zimbabwe. This has raised concern
among many public health experts who
claim that all forms of asbestos are deadly,
and that the risk is particularly pronounced
in poorer countries where government infra-
structures may not be sufficient to protect
worker health. On the other side of the
debate, multinational asbestos corporations
and industry groups claim that the primary
type of asbestos used today, chrysotile
asbestos, presents no appreciable health risk
when used properly and that reports of
exploitation of asbestos workers in develop-
ing countries are highly exaggerated.
One such report, published in the
April-June 1997 issue of the International
Journal ofOccupational and Environmental
Health (IJOEH), describes a "silent epidem-
ic ofasbestos-related diseases" among work-
ers in Brazil, which is the world's fifth
largest producer and consumer of asbestos
products. Much ofthe asbestos mining and
production in Brazil is controlled by multi-
national corporations, and the authors of
the article, Fernanda Giannasi of the
Brazilian Labor Ministry and Annie
Thebaud-Mony of the French National
Institute for Health and Medical Research,
claim that these companies have routinely
exposed workers to asbestos while ignoring
the lung disease and premature death
caused bysuch exposures.
As an example, the authors describe an
investigation into the health of Brazilians
who had been employed at an asbestos
cement plant in the city of Osasco that is
owned by the Swiss-based Eternit
Corporation. According to the reports of
the company medical director at the
Osasco plant, the diseases commonly asso-
ciated with inhaling asbestos were rarely
seen among workers during the plant's 50
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